News
Invited to talk at PEGS 2026 about AI-based antibody design
PEGS 2026 ↗Our team's study on vaccination and Alzheimer's was featured in Viva Longevity channel
Viva Longevity ↗Dr. Kim was promoted to Tenured Associate Professor!
Top Five performers in AIntibody Challenge organized by IQVIA Laboratories with 166 participants from academia, biotech, pharma, and big tech companies.
AIntibody Challenge ↗Gave a tutorial on "AI-guided Antibody Discovery" at PepTalk 2025, San Diego
So honored to be featured in UTHealth Insider news.
UTHealth Insider ↗Awarded NIH Research Project Grant R01 as PI ($3.9M for five years) for data-driven disease subtyping for Alzheimer's disease.
Gave a talk, "AI for Computational Phenotyping and Predicting Accelerated Aging," at UTHealth Houston Neuroscience Research Center and Aging Research Symposium.
Gave a talk "AI/ML to Identify Personalized Treatment Effect from Data" at the Artificial Intelligence in Biomedicine and Healthcare Workshop by McWilliams School of Biomedical Informatics, UTHealth Houston.
Awarded NIH Research Project Grant R01 as PI ($4M for five years) on federated learning for multiple clinical data.
Our work, CancerGPT, was invited for a talk at PathAI.
CancerGPT ↗Gave an invited talk at The Web Conference 2023 Health Day.
The Web Conference 2023 ↗Gave an invited talk at BERD Core, UTHealth McGovern Medical School, and Data Science Core at SBMI.
Honored to serve as a grant review panelist for United Kingdom Research and Innovation.
Served as a grant review panelist for AI in Healthcare (Fonds de recherche du Quebec & Ministry of Innovation, Science & Technology - Israel).
Gave a talk at AI in Health Conference, organized by Rice Ken Kennedy Institute.
AI in Health Conference ↗Our vaccine and Alzheimer's study was invited to testify before the U.S. Department of Health & Human Services.
Our flu vaccination and Alzheimer's study was covered by ScienceDaily.
ScienceDaily ↗Top 10% most cited PLoS One article in 2016.
Paper ↗Selected as an AAIC 2020 Highlighted Poster.
Our team's vaccine and Alzheimer's study was covered by NPR and CNN.
NPR ↗Ranked 2nd in the International DREAM Challenge for Drug Repurposing.
DREAM Challenge ↗Served as a grant review panelist for Luxembourg National Science Foundation.
FNR ↗Initiated the SBMI Datathon Series as an organizer.
SBMI Datathon ↗Awarded Robert Wood Johnson Foundation Health Data 4 Action grant as PI.